For Scientific Institutions, Racial Reconciliation Requires Reparations
By C. Brandon Ogbunu,
Scientific American
| 06. 12. 2020
Antiracism in science must be about much more than challenging the bigoted graybeards of our past such as Ronald A. Fisher.
Ronald Fisher as a steward at the First International Eugenics Conference, 1912 (via wikipedia)
Amidst protests and conversations on racism following several instances of police violence, scientific institutions are reevaluating their approach to dealing with anti-Black racism—extant, historical or symbolic. For example, on Wednesday, June 10, a large segment of the scientific community (and the staffs of prominent journals) participated in a strike, where the goal was to reflect on how Black people—students, trainees, staff, and faculty—are treated, and how we can make the scientific paradigm more inclusive.
This includes several ongoing policy discussions surrounding diversity and inclusion, and very specific exchanges about how we remember and celebrate historical figures. For example, the Society for the Study of Evolution (SSE) is one of many influential scientific societies embroiled in a debate over renaming a prestigious award that currently commemorates Ronald A. Fisher (the R.A. Fisher Prize). Fisher was a pioneer of modern population genetics and one of the most influential scientists of the last century. His influence is as great in genetics as it is statistics, the latter...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...